Search

Your search keyword '"Harriet, Corvol"' showing total 351 results

Search Constraints

Start Over You searched for: "Harriet, Corvol" Remove constraint "Harriet, Corvol"
351 results on '"Harriet, Corvol"'

Search Results

1. Seasonal and climatic influence on respiratory infections in children with cystic fibrosis

2. Associations between respiratory pathogens and lung function in primary ciliary dyskinesia: cross-sectional analysis from the PROVALF-PCD cohort

3. Septin-dependent defense mechanisms against Pseudomonas aeruginosa are stalled in cystic fibrosis bronchial epithelial cells

4. Digital Action Plan (Web App) for Managing Asthma Exacerbations: Randomized Controlled Trial

5. Hordeum murinum aspiration revealed by a pneumopleurocutaneous fistula in a 15-month-old infant

6. Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)

7. Retrospective observational study of the influence of the COVID-19 outbreak on infants’ hospitalisation for acute bronchiolitis

8. Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID-19 in France

9. SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant

10. Leveraging TOPMed imputation server and constructing a cohort-specific imputation reference panel to enhance genotype imputation among cystic fibrosis patients

11. Two-hybrid screening of FAM13A protein partners in lung epithelial cells

12. SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation

13. Flagellin From Pseudomonas aeruginosa Modulates SARS-CoV-2 Infectivity in Cystic Fibrosis Airway Epithelial Cells by Increasing TMPRSS2 Expression

14. Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe

15. Benefits and risks of bronchoalveolar lavage in severe asthma in children

16. Effect of Flagellin Pre-Exposure on the Inflammatory and Antifungal Response of Bronchial Epithelial Cells to Fungal Pathogens

17. Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 Patients

18. Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis

19. Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis

21. Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

22. Bronchial Epithelial Cells on the Front Line to Fight Lung Infection-Causing Aspergillus fumigatus

23. Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation.

24. Pulmonary hemosiderosis in children with Down syndrome: a national experience

25. Whole exome sequencing in three families segregating a pediatric case of sarcoidosis

26. COVID‐19 and pediatric pulmonology: Feedback from an expert center after the first year of the pandemic

27. TMEM16A/ANO1: Current Strategies and Novel Drug Approaches for Cystic Fibrosis

28. MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology

29. miR-636: A Newly-Identified Actor for the Regulation of Pulmonary Inflammation in Cystic Fibrosis

30. Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci.

31. Cumulative Incidence and Risk Factors for Severe Coronavirus Disease 2019 in French People With Cystic Fibrosis

32. Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

33. Risk factors for Pseudomonas aeruginosa airway infection and lung function decline in children with cystic fibrosis

34. CHAC1 Is Differentially Expressed in Normal and Cystic Fibrosis Bronchial Epithelial Cells and Regulates the Inflammatory Response Induced by Pseudomonas aeruginosa

35. Emerging microRNA Therapeutic Approaches for Cystic Fibrosis

36. SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis

37. Opposite Expression of Hepatic and Pulmonary Corticosteroid-Binding Globulin in Cystic Fibrosis Patients

38. Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes

40. Bronchial Epithelial Cells from Cystic Fibrosis Patients Express a Specific Long Non-coding RNA Signature upon Pseudomonas aeruginosa Infection

42. Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

43. Severe central apnea secondary to cerebellar dysplasia in a child: look past Joubert syndrome

44. Retour d’expérience d’un hôpital pédiatrique pendant la crise Covid-19 en Île-de-France

45. SLC6A14, un gène modificateur dans la mucoviscidose

46. Nocturnal hypoventilation in Down syndrome children with or without sleep apnea

47. Variant classifications, databases and genotype-phenotype correlations

48. Respiratory management of spinal muscular atrophy type 1 patients treated with Nusinersen

49. Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis

50. Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis

Catalog

Books, media, physical & digital resources